Marcus A. Conant
Corporate Officer/Principal presso The University of California, San Francisco
Posizioni attive di Marcus A. Conant
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | - | - |
Storia della carriera di Marcus A. Conant
Precedenti posizioni note di Marcus A. Conant
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Direttore Tecnico/Scientifico/R&S | - | - |
| ENZO BIOCHEM, INC. | Direttore/Membro del Consiglio | - | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ENZO BIOCHEM, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Marcus A. Conant
- Esperienza